share_log

T2 Biosystems | CORRESP: CORRESP

T2 Biosystems | CORRESP: CORRESP

T2 Biosystems | CORRESP:信函
美股SEC公告 ·  2024/06/01 01:41

Moomoo AI 已提取核心訊息

T2 Biosystems, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on May 28, 2024. The company seeks to have the registration statement become effective by 4:30 p.m. Washington D.C. time on June 4, 2024, or as soon as possible thereafter. This request was made under Rule 461(a) of the Securities Act of 1933, as amended. T2 Biosystems has asked to be notified of the registration's effectiveness via a phone call to N. Danny Shulman of Latham & Watkins LLP and also expects a written confirmation. John Sperzel, President, CEO, and Chairman of the Board of T2 Biosystems, signed the request.
T2 Biosystems, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on May 28, 2024. The company seeks to have the registration statement become effective by 4:30 p.m. Washington D.C. time on June 4, 2024, or as soon as possible thereafter. This request was made under Rule 461(a) of the Securities Act of 1933, as amended. T2 Biosystems has asked to be notified of the registration's effectiveness via a phone call to N. Danny Shulman of Latham & Watkins LLP and also expects a written confirmation. John Sperzel, President, CEO, and Chairman of the Board of T2 Biosystems, signed the request.
T2 Biosystems已正式要求證券交易所委員會(SEC)加快其有關S-3表格的註冊聲明生效日期,該表格最初於2024年5月28日提交。該公司希望該註冊聲明在2024年6月4日美國華盛頓時間下午4:30或儘可能迅速生效。該請求根據1933年證券法修正案的461(a)條規定而提出。T2 Biosystems要求通過致電Latham& Watkins LLP的N. Danny Shulman獲得有關注冊效力的通知,還期待獲得書面確認。公司的總裁、CEO和董事局主席John Sperzel簽署了此請求。
T2 Biosystems已正式要求證券交易所委員會(SEC)加快其有關S-3表格的註冊聲明生效日期,該表格最初於2024年5月28日提交。該公司希望該註冊聲明在2024年6月4日美國華盛頓時間下午4:30或儘可能迅速生效。該請求根據1933年證券法修正案的461(a)條規定而提出。T2 Biosystems要求通過致電Latham& Watkins LLP的N. Danny Shulman獲得有關注冊效力的通知,還期待獲得書面確認。公司的總裁、CEO和董事局主席John Sperzel簽署了此請求。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息